4925 Results

People

  1. Giralt
    Giralt
  2. Berger
    Berger
  3. Morrow
    Morrow
  4. Horwitz
    Horwitz
  5. Ladanyi
    Ladanyi
  6. Lee
    Lee
  7. Adusumilli
    Adusumilli
  8. Hyman
    Hyman
  9. Perales
    Perales
  10. Solit
    Solit

Groups

  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)
  7. Center for Hematologic Malignancies (764)
  8. Hematologic Malignancies, Division of (714)
  9. Department of Pathology and Laboratory Medicine (653)
  10. Population Sciences Research Program (632)
  1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Resource-stratification of National Comprehensive Cancer Network (NCCN®) Head and Neck Cancers Guideline
    Meeting Abstract

    Carlson, R. W.; Nardi, E.; Bacigalupo, J.; Darlow, S.; McClure, J. S.; Pfister, D.
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Chemotherapy-induced thrombocytopenia (CIT) in metastatic colorectal cancer (mCRC) patients
    Meeting Abstract

    Cetin, K.; Toler, A.; Eisen, M.; Soff, G. A.
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Progression-free survival (PFS) by independent review and updated overall survival (OS) results from Alliance A031203 trial (CABOSUN): Cabozantinib versus sunitinib as initial targeted therapy for patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Choueiri, T. K.; Hessel, C.; Halabi, S.; Sanford, B.; Hahn, O.; Michaelson, M. D.; Walsh, M.; Olencki, T.; Picus, J.; Small, E. J.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • The TRITON clinical trial programme: Evaluation of the PARP inhibitor rucaparib in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD)
    Meeting Abstract

    Chowdhury, S.; Abida, W.; Arija, J. A.; Daugaard, G.; Fizazi, K.; Gez, E.; Heidenreich, A.; Joly Lobbedez, F.; McDermott, R.; Merseburger, A. S.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Avelumab treatment in chemotherapy-naïve patients with distant metastatic Merkel cell carcinoma (mMCC)
    Meeting Abstract

    D'Angelo, S. P.; Russell, J.; Hassel, J.; Lebbé, C.; Chmielowski, B.; Rabinowits, G.; Terheyden, P.; Brownell, I.; Zwiener, I.; Bajars, M.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitors following targeted therapies in MITF family translocation renal cell carcinomas
    Meeting Abstract

    Boileve, A.; Carlo, M.; Barthelemy, P.; Oudard, S.; Borchiellini, D.; Voss, M.; George, S.; Chevreau, C.; Landman-Parker, J.; Tabone, M. D.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Analysis of overall survival by tumor response in MONARCH 1, a phase 2 study of abemaciclib, a CDK4 and CDK6 inhibitor, in women with HR+/HER2- metastatic breast cancer (MBC) after chemotherapy for advanced disease
    Meeting Abstract

    Cortés, J.; Rugo, H. S.; Tolaney, S. M.; Diéras, V.; Patt, D.; Wildiers, H.; Nanda, S.; Koustenis, A.; Dickler, M. N.; Baselga, J.
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA)
    Meeting Abstract

    Berman, B.; Konner, J.; Belum, V. R.; Dion, H.; Ciccolini, K.; Kitts, S.; Ye, R.; Ravipaty, S.; Akmaev, V. R.; Sarangarajan, R.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • A Phase III, randomized, double-blind, multicenter study of adjuvant nivolumab vs placebo in patients (pts) with high-risk invasive urothelial carcinoma (UC; CheckMate 274)
    Meeting Abstract

    Bajorin, D.; Galsky, M. D.; Gschwend, J. E.; Tomita, Y.; Azrilevich, A.; Witjes, F.
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Impact of cisplatin-based therapy on long-term survival in advanced urinary tract cancer (aUTC). A retrospective international study of invasive/advanced cancer of the urothelium (RISC)
    Meeting Abstract

    Bamias, A.; Tzannis, K.; Bamia, C.; Harshman, L. C.; Crabb, S.; Wong, Y. N.; Pal, S. K.; De Giorgi, U.; Ladoire, S.; Agarwal, N.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save